Extended half-life factor VIII for immune tolerance induction in haemophilia

Haemophilia. 2016 Nov;22(6):e552-e554. doi: 10.1111/hae.13064. Epub 2016 Sep 19.

Authors

L M Malec^{1

2}, J Journeycake^{3

4}, M V Ragni^{1

2}

Affiliations

¹ University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
² Hemophilia Center of Western Pennsylvania, Pittsburgh, PA, USA.
³ University of Texas Southwestern School of Medicine, Dallas, TX, USA.
⁴ Bleeding Disorder and Thrombosis, Program Pauline Allen Gill Center for Cancer and Blood Disorders, Dallas, TX, USA.

PMID: 27640873
DOI: 10.1111/hae.13064

No abstract available

Publication types

Letter

MeSH terms

Child
Factor VIII / administration & dosage*
Factor VIII / immunology
Factor VIII / pharmacokinetics*
Female
Half-Life
Hemophilia A / drug therapy*
Hemophilia A / immunology
Hemophilia A / metabolism*
Humans
Infant
Male

Substances

Factor VIII